{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:16:22Z","timestamp":1790914582677,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04326-6","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T11:14:30Z","timestamp":1754478870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ethnic differences in early blood tacrolimus concentrations after kidney transplantation: a retrospective observational study"],"prefix":"10.1186","volume":"26","author":[{"given":"Eilidh C.","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Randall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad A.","family":"Khurram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed M.","family":"Yaqoob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"issue":"1","key":"4326_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1001\/jama.2017.19152","volume":"319","author":"TS Purnell","year":"2018","unstructured":"Purnell TS, Luo X, Cooper LA, Massie AB, Kucirka LM, Henderson ML, et al. Association of race and ethnicity with live donor kidney transplantation in the united States from 1995 to 2014. JAMA. 2018;319(1):49\u201361.","journal-title":"JAMA"},{"issue":"1","key":"4326_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","volume":"12","author":"CP Kovesdy","year":"2022","unstructured":"Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl (2011). 2022;12(1):7\u201311.","journal-title":"Kidney Int Suppl (2011)"},{"issue":"12","key":"4326_CR3","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1681\/ASN.2022080890","volume":"33","author":"DC Crews","year":"2022","unstructured":"Crews DC, Patzer RE, Cervantes L, Knight R, Purnell TS, Powe NR, et al. Designing interventions addressing structural racism to reduce kidney health disparities: A report from a National Institute of diabetes and digestive and kidney diseases workshop. J Am Soc Nephrol. 2022;33(12):2141\u201352.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"4326_CR4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41581-021-00520-5","volume":"18","author":"D Mohottige","year":"2022","unstructured":"Mohottige D, Gibson K. Staying on track to achieve Racial justice in kidney care. Nat Rev Nephrol. 2022;18(2):72\u20133.","journal-title":"Nat Rev Nephrol"},{"issue":"7520","key":"4326_CR5","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1136\/bmj.38569.471007.AE","volume":"331","author":"AC Webster","year":"2005","unstructured":"Webster AC, Woodroffe RC, Taylor RS, Chapman JR, Craig JC. Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data. BMJ. 2005;331(7520):810.","journal-title":"BMJ"},{"issue":"Suppl 3","key":"4326_CR6","first-page":"S1","volume":"9","author":"KDIGO clinical practice guideline for the","year":"2009","unstructured":"KDIGO clinical practice guideline for the. Care of kidney transplant recipients. Am J Transpl. 2009;9(Suppl 3):S1\u2013155.","journal-title":"Am J Transpl"},{"issue":"1","key":"4326_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/01.TP.0000162980.68628.5A","volume":"80","author":"KL Hardinger","year":"2005","unstructured":"Hardinger KL, Bohl DL, Schnitzler MA, Lockwood M, Storch GA, Brennan DC. A randomized, prospective, Pharmacoeconomic trial of tacrolimus versus cyclosporine in combination with thymoglobulin in renal transplant recipients. Transplantation. 2005;80(1):41\u20136.","journal-title":"Transplantation"},{"key":"4326_CR8","first-page":"23","volume":"11","author":"L Chen","year":"2018","unstructured":"Chen L, Prasad GVR. CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment. Pharmgenomics Pers Med. 2018;11:23\u201333.","journal-title":"Pharmgenomics Pers Med"},{"issue":"4","key":"4326_CR9","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/86882","volume":"27","author":"P Kuehl","year":"2001","unstructured":"Kuehl P, Zhang J, Lin Y, Lamba J, Assem M, Schuetz J, et al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet. 2001;27(4):383\u201391.","journal-title":"Nat Genet"},{"issue":"10","key":"4326_CR10","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1097\/TP.0000000000000149","volume":"97","author":"KR Richards","year":"2014","unstructured":"Richards KR, Hager D, Muth B, Astor BC, Kaufman D, Djamali A. Tacrolimus trough level at discharge predicts acute rejection in moderately sensitized renal transplant recipients. Transplantation. 2014;97(10):986\u201391.","journal-title":"Transplantation"},{"key":"4326_CR11","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.3389\/fimmu.2019.02912","volume":"10","author":"T Song","year":"2019","unstructured":"Song T, Yin S, Jiang Y, Huang Z, Liu J, Wang Z, et al. Increasing time in therapeutic range of tacrolimus in the first year predicts better outcomes in Living-Donor kidney transplantation. Front Immunol. 2019;10:2912.","journal-title":"Front Immunol"},{"issue":"9","key":"4326_CR12","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1093\/ndt\/16.9.1905","volume":"16","author":"C Staatz","year":"2001","unstructured":"Staatz C, Taylor P, Tett S. Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation. Nephrol Dial Transpl. 2001;16(9):1905\u20139.","journal-title":"Nephrol Dial Transpl"},{"issue":"2","key":"4326_CR13","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","volume":"12","author":"J Sellar\u00e9s","year":"2012","unstructured":"Sellar\u00e9s J, de Freitas DG, Mengel M, Reeve J, Einecke G, Sis B, et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transpl. 2012;12(2):388\u201399.","journal-title":"Am J Transpl"},{"key":"4326_CR14","doi-asserted-by":"publisher","first-page":"11027","DOI":"10.3389\/ti.2023.11027","volume":"36","author":"FA von Samson-Himmelstjerna","year":"2023","unstructured":"von Samson-Himmelstjerna FA, Messtorff ML, Kakavand N, Eisenberger U, Korth J, Lange U, et al. The tacrolimus concentration\/dose ratio does not predict early complications after kidney transplantation. Transpl Int. 2023;36:11027.","journal-title":"Transpl Int"},{"issue":"6","key":"4326_CR15","doi-asserted-by":"publisher","first-page":"e14606","DOI":"10.1111\/ctr.14606","volume":"36","author":"JCM Chua","year":"2022","unstructured":"Chua JCM, Mount PF, Lee D. Lower versus higher starting tacrolimus dosing in kidney transplant recipients. Clin Transpl. 2022;36(6):e14606.","journal-title":"Clin Transpl"},{"issue":"3","key":"4326_CR16","doi-asserted-by":"publisher","first-page":"240","DOI":"10.4103\/ijn.IJN_278_20","volume":"32","author":"TY Raj","year":"2022","unstructured":"Raj TY, Fernando ME, Srinivasa Prasad ND, Sujit S, Valavan KT, Harshavardhan TS, et al. Efficacy and outcomes of CYP3A5 Genotype-Based tacrolimus dosing compared to conventional body Weight-based dosing in living donor kidney transplant recipients. Indian J Nephrol. 2022;32(3):240\u20136.","journal-title":"Indian J Nephrol"},{"issue":"4","key":"4326_CR17","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1177\/1526924819873905","volume":"29","author":"B Largeau","year":"2019","unstructured":"Largeau B, Guellec CB-L, Longuet H, Lesne P, Bouvarel A, Pr\u00e9teseille L, et al. Comparison of tacrolimus starting doses based on CYP3A5 phenotype or genotype in kidney transplant recipients. Prog Transpl. 2019;29(4):300\u20138.","journal-title":"Prog Transpl"},{"key":"4326_CR18","doi-asserted-by":"publisher","first-page":"101752","DOI":"10.1016\/j.eclinm.2022.101752","volume":"55","author":"B Shi","year":"2023","unstructured":"Shi B, Liu Y, Liu D, Yuan L, Guo W, Wen P, et al. Genotype-guided model significantly improves accuracy of tacrolimus initial dosing after liver transplantation. EClinicalMedicine. 2023;55:101752.","journal-title":"EClinicalMedicine"},{"issue":"7","key":"4326_CR19","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1111\/ajt.13691","volume":"16","author":"N Shuker","year":"2016","unstructured":"Shuker N, Bouamar R, van Schaik RHN, Clahsen-van Groningen MC, Damman J, Baan CC, et al. A randomized controlled trial comparing the efficacy of Cyp3a5 Genotype\u2010Based with Body\u2010Weight\u2010Based tacrolimus dosing after living donor kidney transplantation. Am J Transplant. 2016;16(7):2085\u201396.","journal-title":"Am J Transplant"},{"issue":"7","key":"4326_CR20","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1001\/jama.2021.13304","volume":"326","author":"A Flanagin","year":"2021","unstructured":"Flanagin A, Frey T, Christiansen SL, Committee AMS. Updated guidance on the reporting of race and ethnicity in medical and science journals. JAMA. 2021;326(7):621\u20137.","journal-title":"JAMA"},{"issue":"2","key":"4326_CR21","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41581-021-00501-8","volume":"18","author":"ND Eneanya","year":"2022","unstructured":"Eneanya ND, Boulware LE, Tsai J, Bruce MA, Ford CL, Harris C, et al. Health inequities and the inappropriate use of race in nephrology. Nat Rev Nephrol. 2022;18(2):84\u201394.","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"4326_CR22","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1056\/NEJMms2004740","volume":"383","author":"DA Vyas","year":"2020","unstructured":"Vyas DA, Eisenstein LG, Jones DS. Hidden in plain Sight - Reconsidering the use of race correction in clinical algorithms. N Engl J Med. 2020;383(9):874\u201382.","journal-title":"N Engl J Med"},{"key":"4326_CR23","doi-asserted-by":"crossref","unstructured":"Sharma S, Mari\u00f1o-Ram\u00edrez L, Jordan IK. Race, ethnicity, and pharmacogenomic variation in the united States and the united Kingdom. Pharmaceutics. 2023;15(7).","DOI":"10.3390\/pharmaceutics15071923"},{"key":"4326_CR24","unstructured":"Office of Health Equity.: Health Resources and Services Administration. 2024 [Available from: https:\/\/www.hrsa.gov\/about\/organization\/bureaus\/ohe"},{"issue":"10","key":"4326_CR25","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1097\/TP.0000000000000708","volume":"99","author":"E St\u00f8rset","year":"2015","unstructured":"St\u00f8rset E, \u00c5sberg A, Skauby M, Neely M, Bergan S, Bremer S, et al. Improved tacrolimus target concentration achievement using computerized dosing in renal transplant Recipients\u2013A prospective, randomized study. Transplantation. 2015;99(10):2158\u201366.","journal-title":"Transplantation"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04326-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04326-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04326-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T21:18:13Z","timestamp":1757366293000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04326-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4326"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04326-6","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,6]]},"assertion":[{"value":"30 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted as an observational service analysis of the existing transplant immunosuppression policy at the Royal London Hospital. Research ethics committee approval was deemed unnecessary under the terms of the UK Policy Framework for Health and Social Care Research, using their online decision support tool (). The project adheres to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"Informed consent to for their data to be used in this project was not sought from patients. It is not required under UK law for use of patient data in clinical audit (see General Medical Council document Using and Disclosing Patient Information for Secondary Purposes paragraphs 95 and 96 (). Institutional approval came from the Barts Health Clinical Effectiveness Unit.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"436"}}